Waking Up to REMS (Part 1): Don't Believe the Lack of Hype
This article was originally published in RPM Report
Executive Summary
FDA's top management can't be accused of overstating the importance of the agency's new drug safety tools. But sponsors need to wake up to the reality: the REMS are a critical fact of drug development and marketing.